Early glycoxidation damage in brains from Down's syndrome

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Down syndrome (trisomy 21) is linked to premature aging and cognitive decline, mirroring Alzheimer disease pathology.
• Early brain development issues and later neuronal loss in Down syndrome may stem from amyloid beta-peptide overproduction and heightened cellular oxidation.
• Chromosome 21 encodes superoxide dismutase and amyloid beta precursor protein, leading to their overabundance in Down syndrome.

Purpose of the Study:

• To investigate the presence and levels of lipid and protein oxidation markers in the Down syndrome fetal brain cortex.
• To quantify specific glycation end products implicated in cellular oxidation processes.

Main Methods:

• Analysis of Down syndrome fetal brain cortex samples.
• Measurement of lipid and protein oxidation markers.
• Quantification of two forms of glycation end products.

Main Results:

• Significantly elevated levels of lipid and protein oxidation markers were observed in Down syndrome fetal brains compared to controls.
• Increased quantities of specific glycation end products were detected in the Down syndrome fetal brains.
• These findings indicate an early onset of accelerated oxidative stress and glycoxidation in the developing brain in Down syndrome.

Conclusions:

• Accelerated brain glycoxidation occurs very early in the life of individuals with Down syndrome.
• Increased oxidative stress markers suggest a significant role for oxidation in the neuropathology of Down syndrome.
• These early molecular changes may contribute to the cortical dysgenesis and neurodegeneration observed in Down syndrome.